Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("DEN OTTER, Willem")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 44

  • Page / 2
Export

Selection :

  • and

Presence of cytotoxic B220+CD3+CD4-CD8- cells correlates with the therapeutic efficacy of lymphoma treatment with IL-2 and/or IL-12MASZTALERZ, Agnieszka; EVERSE, Linda Ann; DEN OTTER, Willem et al.Journal of immunotherapy (1997). 2004, Vol 27, Num 2, pp 107-115, issn 1524-9557, 9 p.Article

Local interleukin 2 therapy is most effective against cancer when injected intratumourallyJACOBS, John J. L; SPARENDAM, Derek; DEN OTTER, Willem et al.Cancer immunology and immunotherapy. 2005, Vol 54, Num 7, pp 647-654, issn 0340-7004, 8 p.Article

What is Cancer? Theories on CarcinogenesisDEN OTTER, Willem; ROOT-BERNSTEIN, Robert; KOTEN, Jan-Willem et al.Anticancer research. 1999, Vol 19, Num 6A, pp 4599-4933, issn 0250-7005, 334 p.Serial Issue

Cell damage, aging and transformation : A multilevel analysis of carcinogenesisRUBIN, H.Anticancer research. 1999, Vol 19, Num 6A, pp 4877-4886, issn 0250-7005Article

Morphology of human carcinogenesisIOACHIM, H. L.Anticancer research. 1999, Vol 19, Num 6A, pp 4627-4643, issn 0250-7005Article

Role of p53 and apoptosis in carcinogenesisXIN WEI WANG.Anticancer research. 1999, Vol 19, Num 6A, pp 4759-4771, issn 0250-7005Article

Genetic, epigenetic, dysgenetic and non-genetic mechanisms in tumorigenesis. II. Further delineation of the rate limiting stepSIMONS, J. W. I. M.Anticancer research. 1999, Vol 19, Num 6A, pp 4781-4789, issn 0250-7005Article

The role of molecular discreteness in normal and cancerous growthMICHAELSON, J.Anticancer research. 1999, Vol 19, Num 6A, pp 4853-4867, issn 0250-7005Article

Complementarity and contradiction in cancer research : The role of hierarchies in carcinogenesisROOT-BERNSTEIN, R. S.Anticancer research. 1999, Vol 19, Num 6A, pp 4915-4918, issn 0250-7005Article

Human tumor virusesHOPPE-SEYLER, F; BUTZ, K.Anticancer research. 1999, Vol 19, Num 6A, pp 4747-4758, issn 0250-7005Article

Cancer cell cycle controlFUNK, J. O.Anticancer research. 1999, Vol 19, Num 6A, pp 4772-4780, issn 0250-7005Article

Growth regulatory factors and carcinogenesis : The roles played by transforming growth factor β, its receptors and signaling pathwaysKELLY, D. L; RIZZINO, A.Anticancer research. 1999, Vol 19, Num 6A, pp 4791-4807, issn 0250-7005Article

Spontaneous remission of cancer-A thyroid hormone dependent phenomenon?HERCBERGS, A.Anticancer research. 1999, Vol 19, Num 6A, pp 4839-4844, issn 0250-7005Article

Genomic instability : First step to carcinogenesisSCHMUTTE, C; FISHEL, R.Anticancer research. 1999, Vol 19, Num 6A, pp 4665-4696, issn 0250-7005Article

Pernicious cachexia : A different view of cancerZAJICEK, G.Anticancer research. 1999, Vol 19, Num 6A, pp 4907-4912, issn 0250-7005Article

Evaluation : Complementarity and contradictoriness of cancer theories. A genetic perspectiveDEN OTTER, W.Anticancer research. 1999, Vol 19, Num 6A, pp 4913-4914, issn 0250-7005Article

Mechanisms of macrophage cytotoxicity in IL-2 and IL-12 mediated tumour regressionMASZTALERZ, Agnieszka; VAN ROOIJEN, Nice; DEN OTTER, Willem et al.Cancer immunology and immunotherapy. 2003, Vol 52, Num 4, pp 235-242, issn 0340-7004, 8 p.Article

The roles of telomeres and telomerase in cellular immortalization and the development of cancerKLINGELHUTZ, A. J.Anticancer research. 1999, Vol 19, Num 6A, pp 4823-4830, issn 0250-7005Article

Predictive value of CD8highCD57+ lymphocyte subset in interferon therapy of patients with renal cell carcinomaCHARACIEJUS, Dainius; PASUKONIENE, Vita; KAZLAUSKAITE, Nijole et al.Anticancer research. 2002, Vol 22, Num 6B, pp 3679-3683, issn 0250-7005, 5 p.Article

OncogenesTODD, R; WONG, D. T. W.Anticancer research. 1999, Vol 19, Num 6A, pp 4729-4746, issn 0250-7005Article

The role of oval cells and Gap Junctional intercellular communication in hepatocarcinogenesisRUCH, R. J; TROSKO, J. E.Anticancer research. 1999, Vol 19, Num 6A, pp 4831-4838, issn 0250-7005Article

Prediction of Response in Cancer ImmunotherapyCHARACIEJUS, Dainius; JACOBS, John J. L; PASUKONIENE, Vita et al.Anticancer research. 2011, Vol 31, Num 2, pp 639-647, issn 0250-7005, 9 p.Article

Changes in cytokine profile during local IL-2 therapy in cancer patientsTOMOVA, Radosveta; POMAKOV, Javor; JACOBS, John J. L et al.Anticancer research. 2006, Vol 26, Num 3A, pp 2037-2047, issn 0250-7005, 11 p.Article

Therapeutic effect of a single peritumoural dose of IL-2 on transplanted murine breast cancerMOISEEVA, Ekaterina V; MERKULOVA, Irina B; BIJLEVELD, Caspaar et al.Cancer immunology and immunotherapy. 2003, Vol 52, Num 8, pp 487-496, issn 0340-7004, 10 p.Article

Toward a philosophy of cancer researchROOT-BERNSTEIN, R. S; OTTER, W. D.Anticancer research. 1999, Vol 19, Num 6A, pp 4603-4612, issn 0250-7005Article

  • Page / 2